Cannabinoid receptor 2 selective agonists and Alzheimer's disease: An insight into the therapeutic potentials

被引:16
作者
Magham, Sai Varshini [1 ]
Thaggikuppe Krishnamurthy, Praveen [1 ]
Shaji, Neenu [1 ]
Mani, Lalithkumar [1 ]
Balasubramanian, Shivaramakrishnan [1 ]
机构
[1] JSS Acad Higher Educ & Res, Dept Pharmacol, JSS Coll Pharm, Ooty, India
关键词
CB1; CNS; endocannabinoid system (ECS); neuroprotection; TRANSGENIC MOUSE MODEL; CENTRAL-NERVOUS-SYSTEM; ACID AMIDE HYDROLASE; CB2; RECEPTOR; AMYLOID-BETA; IN-VITRO; ENDOCANNABINOID SYSTEM; FUNCTIONAL SELECTIVITY; SIGNAL-TRANSDUCTION; ACTIVATION;
D O I
10.1002/jnr.24933
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Endocannabinoid system has been extensively studied in recent decades, particularly the cannabinoid receptors CB1 and CB2, due to their important role in neuroinflammation. Among these, CB2 has gained prominence due to its selective overexpression in glial cells during neuroinflammation. In contrast to CB1 agonists, CB2 agonists have no side effects such as ataxia, hypothermia, euphoria, psychological, or addiction liabilities. CB2 and its selective agonists' above-mentioned unique properties have become a research focus in neurodegenerative disorders such as Alzheimer's disease (AD). The review discusses the neuroprotective role of CB receptors, particularly CB2, in AD, as well as the significance and limitations of this research.
引用
收藏
页码:2888 / 2905
页数:18
相关论文
共 164 条
[121]   Medical Cannabis Use in Glioma Patients Treated at a Comprehensive Cancer Center in Florida [J].
Reblin, Maija ;
Sahebjam, Solmaz ;
Peeri, Noah C. ;
Martinez, Yessica C. ;
Thompson, Zachary ;
Egan, Kathleen M. .
JOURNAL OF PALLIATIVE MEDICINE, 2019, 22 (10) :1202-1207
[122]   Mutant APP and amyloid beta-induced defective autophagy, mitophagy, mitochondrial structural and functional changes and synaptic damage in hippocampal neurons from Alzheimer's disease [J].
Reddy, P. Hemachandra ;
Yin, XiangLing ;
Manczak, Maria ;
Kumar, Subodh ;
Pradeepkiran, Jangampalli Adi ;
Vijayan, Murali ;
Reddy, Arubala P. .
HUMAN MOLECULAR GENETICS, 2018, 27 (14) :2502-2516
[123]   Endocannabinoid Binding to the Cannabinoid Receptors: What Is Known and What Remains Unknown [J].
Reggio, Patricia H. .
CURRENT MEDICINAL CHEMISTRY, 2010, 17 (14) :1468-1486
[124]   Neuroprotective effects of the cannabigerol quinone derivative VCE-003.2 in SOD1G93A transgenic mice, an experimental model of amyotrophic lateral sclerosis [J].
Rodriguez-Cueto, Carmen ;
Santos-Garcia, Irene ;
Garcia-Toscano, Laura ;
Espejo-Porras, Francisco ;
Bellido, MLuz ;
Fernandez-Ruiz, Javier ;
Munoz, Eduardo ;
de Lago, Eva .
BIOCHEMICAL PHARMACOLOGY, 2018, 157 :217-226
[125]   Cannabinoid receptor type 2 activation induces a microglial anti-inflammatory phenotype and reduces migration via MKP induction and ERK dephosphorylation [J].
Romero-Sandoval, Edgar Alfonso ;
Horvath, Ryan ;
Landry, Russell P. ;
DeLeo, Joyce A. .
MOLECULAR PAIN, 2009, 5
[126]   Effects of THC on driving performance, physiological state and subjective feelings relative to alcohol [J].
Ronen, Adi ;
Gershon, Pnina ;
Drobiner, Harlan ;
Rabinovich, Alex ;
Bar-Hamburger, Rachel ;
Mechoulam, Raphael ;
Cassuto, Yair ;
Shinar, David .
ACCIDENT ANALYSIS AND PREVENTION, 2008, 40 (03) :926-934
[127]   The endocannabinoid system in anxiety, fear memory and habituation [J].
Ruehle, S. ;
Rey, A. Aparisi ;
Remmers, F. ;
Lutz, B. .
JOURNAL OF PSYCHOPHARMACOLOGY, 2012, 26 (01) :23-39
[128]  
Sajjad R, 2018, INDIAN J PHARM SCI, V80, P581
[129]   Virtual screening of novel CB2 ligands using a comparative model of the human cannabinoid CB2 receptor [J].
Salo, OMH ;
Raitio, KH ;
Savinainen, JR ;
Nevalainen, T ;
Lahtela-Kakkonen, M ;
Laitinen, JT ;
Järvinen, T ;
Poso, A .
JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (23) :7166-7171
[130]   Rimonabant: FromRIO to Ban [J].
Sam, Amir H. ;
Salem, Victoria ;
Ghatei, Mohammad A. .
JOURNAL OF OBESITY, 2011, 2011